This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Bacillus clausii is a probiotic used to restore normal gastrointestinal flora.
- Generic Name
- Bacillus clausii
- DrugBank Accession Number
- DB16537
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- B. clausii
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Abdominal pain ••• ••• •••••••••• Treatment of Abnormal intestinal absorption ••• ••• •••••••••• Treatment of Diarrhea ••• ••• •••••••••• Treatment of Gas ••• ••• •••••••••• Treatment of Intestinal bacteria flora disturbance ••• ••• •••••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Enterogermina 2 Billions hard capsules Capsule 2000000000 spores Oral SANOFI-AVENTIS (MALAYSIA) SDN. BHD. 2020-09-08 2022-01-14 Malaysia 
Enterogermina 2 Billions/5 ml oral suspension Suspension 2000000000 spores/5mL Oral DKSH MALAYSIA SDN BHD 2020-09-08 Not applicable Malaysia
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- KQ2N4RPK58
- CAS number
- Not Available
References
- General References
- AIFA: Enterogermina (Bacillus clausii) Oral Suspension [Link]
- External Links
- 2600050
- Wikipedia
- Bacillus_clausii
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Gastroenteritis Acute 2 4 Completed Treatment Gastrointestinal Diseases 1 4 Completed Treatment Infantile Diarrhea 1 4 Completed Treatment Irritable Bowel Syndrome (IBS) 1 3 Completed Treatment Diarrhea 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Suspension Oral Capsule Oral 2000000000 spores Suspension Oral 2000000000 spores/5mL Suspension Oral 2000000000 1/1 - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at February 02, 2021 22:10 / Updated at May 05, 2021 20:32